U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07587021) titled 'Study of YOLT-203 in Children and Adults With Primary Hyperoxaluria Type 1 (PH1)' on May 01.
Brief Summary: This study will be conducted to evaluate the efficacy and safety of YOLT-203 in children and adults with Primary Hyperoxaluria Type 1.
After the initial randomized, 6-month double-blind, placebo-controlled period, participants who were initially assigned to placebo will receive a single-dose of YOLT-203 treatment whereas participants in the YOLT-203 group will receive a single-dose of placebo infusion.
Study Start Date: June, 2026
Study Type: INTERVENTIONAL
Condition:
Primary Hyperoxaluria Type 1
PH1
Intervention:
GENETI...